1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Nokia's first finger-touch phone. This GSM phone with US 3G sports a large touch display, 3-megapixel auto-focus camera, VGA video capture, GPS, Wi-Fi, a memory card slot, accelerometer, and ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

Ryzen 7 5800X vs. Ryzen 9 5900X vs. 5950X GPU on sale, AMD Radeon RX 7800 XT release date price specs and benchmarks on sale, RX 6700 XT benchmark with Core i9 10900K 1080p 1440p Ultrawide on sale, ...